Aflibercept as Adjunctive Treatment for Filtration Surgery in Neovascular Glaucoma

NCT04970251 · clinicaltrials.gov ↗

NA

Phase

COMPLETED

Status

5

Enrollment

OTHER

Sponsor class

Conditions

Intraocular Pressure
Neovascular Glaucoma
Vascular Endothelial Growth Factor Overexpression
Glaucoma Secondary to Eye Inflammation

Interventions

DRUG: Aflibercept Ophthalmic

Sponsor

Siriraj Hospital